Skip to Content

KU 430 (Lansoprazole Delayed-Release 30 mg)

Pill with imprint KU 430 is Purple / White, Capsule-shape and has been identified as Lansoprazole Delayed-Release 30 mg. It is supplied by Lannett Company, Inc..

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 430

Lansoprazole delayed-release 30 mg KU 430

Lansoprazole Delayed-Release

Imprint
KU 430
Strength
30 mg
Color
Purple / White
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
62175-0430
Inactive Ingredients
FD&C Blue No. 1, FD&C Red No. 3, gelatin, hypromellose 2910 (6 mPa.s), magnesium carbonate, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 6000, polysorbate 80, sodium lauryl sulfate, sodium starch glycolate type A corn, magnesium silicate, titanium dioxide, shellac, isopropyl alcohol, butyl alcohol, ammonia, alcohol, ferrosoferric oxide, aluminum chlorohydrex propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.